Clinical Trial Update: A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia [Phase 4]

View source ↗

Summary

A Phase 4, randomized multicenter trial evaluating Kanglaite Injection for cancer cachexia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• Kanglaite Injection (Kanglaite)

Snippet

Sponsor: Zhejiang Kanglaite Pharmaceutical Co.Ltd | Conditions: Cancer Cachexia | Phase 4 | Status: UNKNOWN